Awakn Life Sciences Corp.: Awakn Life Sciences Initiates Feasibility Study for MDMA Using Catalent's Zydis Orally Disintegrating Tablet (ODT) Technology

Toronto, Ontario--(Newsfile Corp. - February 9, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company developing therapeutics to treat addiction with

Related Keywords

Toronto ,Ontario ,Canada ,Gordo Whittaker ,Anthony Tennyson ,Linkedin Facebook ,Schwierige Zeiten ,Shaun Mcnulty ,Awakn Life Sciences ,Newsfile Corp ,Awakn Life Sciences Corp ,Life Sciences ,Alcohol Use Disorder ,Awakn Life ,Awakn ,Life ,Ciences ,Orp ,Nitiates ,Feasibility ,Study ,Dma ,Sing ,Catalent ,Zydis ,Rally ,Disintegrating ,Tablet ,Technology ,